Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GMDA

Gamida Cell (GMDA) Stock Price, News & Analysis

Gamida Cell logo

About Gamida Cell Stock (NASDAQ:GMDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.01
$0.40
52-Week Range
N/A
Volume
23.04 million shs
Average Volume
9.20 million shs
Market Capitalization
$5.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GMDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GMDA Stock News Headlines

What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.tc pixel
Q4 2023 Gamida Cell Ltd Earnings Call
Why Gamida Cell Shares Are Falling Today
See More Headlines

GMDA Stock Analysis - Frequently Asked Questions

Gamida Cell Ltd. (NASDAQ:GMDA) issued its earnings results on Monday, August, 14th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.13.

Gamida Cell (GMDA) raised $50 million in an initial public offering (IPO) on Friday, October 26th 2018. The company issued 3,600,000 shares at $13.00-$15.00 per share. BMO Capital Markets and RBC Capital Markets served as the underwriters for the IPO and Needham & Company Oppenheimer & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gamida Cell investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), Bank of America (BAC), JPMorgan Chase & Co. (JPM), Zomedica (ZOM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
8/14/2023
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GMDA
CIK
1600847
Fax
N/A
Employees
143
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.63)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63 million
Net Margins
N/A
Pretax Margin
-3,531.17%
Return on Equity
N/A
Return on Assets
-57.59%

Debt

Debt-to-Equity Ratio
213.14
Current Ratio
2.16
Quick Ratio
2.09

Sales & Book Value

Annual Sales
$1.78 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
154,051,000
Free Float
143,699,000
Market Cap
$5.04 million
Optionable
Optionable
Beta
0.93

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:GMDA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners